Collaboration Between Mohs and Surgical Subspecialists in the Treatment of Advanced Nonmelanoma Skin Cancer.

Authors

Caroline L Mortelliti, Haley A Neff, Brenda T Solomon, Jacqueline S Stevens, Nina A Ran, Abigail H Waldman, Rosh K Sethi, Eleni M Rettig, Elizabeth J Lilley, Ann W Silk, Emily S Ruiz

Published in

Head & neck. Jul 12, 2026. Epub Jul 12, 2026.

Abstract

Locally advanced and metastatic nonmelanoma skin cancers are frequently managed with operating room (OR)-based resection, lacking real-time margin assessment. Mohs micrographic surgery provides immediate margin evaluation but is limited in deeply invasive or metastatic disease. A coordinated approach combines the strengths of both strategies.
Retrospective cohort study of patients with locally advanced tumors, with or without regional metastases, treated with Mohs surgery followed by OR resection.
Twenty-one patients had median follow-up of 30 (IQR, 14-87) weeks. Mohs cleared the peripheral margin in all cases and the deep margin in 11 (52%) cases. Ten (48%) cases required OR resection of the deep margin, and 10 (48%) required resection of metastatic disease. Median time between surgeries was 2 (IQR, 1-16) days. Three patients (14%) developed recurrence. No disease-specific deaths occurred.
Coordinating Mohs surgery with OR resection enables full margin assessment, surgical clearance of extensive disease, and immediate reconstruction.

PMID:
42437731
Bibliographic data and abstract were imported from PubMed on 13 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.